MedTrace Logo

Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis

NCT04631458 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-09-16

No results posted yet for this study

Summary

Patients with Myeloproliferative neoplasms are at particular risk for developing arterial and venous thrombosis, especially thrombosis in the splanchnic venous system. The patho-physiology and natural history of MPN related SVT is poorly understood and treatment algorithms vary greatly. This is of considerable importance since the morbidity and mortality in this group of patients is high. This study aims to observe patients with MPN related SVT over a period of five years to document their clinical progress. Methods of observation include clinical assessment, standard investigations and laboratory based research investigations

Conditions

  • Myeloproliferative Neoplasm
  • Splanchnic Vein Thrombosis
  • Splanchnic Venous Thrombosis
  • Myeloproliferative Disorders

Interventions

OTHER

standard of care.

Observational trial.

Sponsors & Collaborators

  • University Hospital Birmingham

    collaborator OTHER

  • Royal Free Hospital NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-12
Primary Completion
2021-12-30
Completion
2021-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04631458 on ClinicalTrials.gov